Tustin-based Toshiba America Medical Systems has received FDA approval for its ultrasound software that can help detect a patient's risk of developing cardiovascular disease – before an episode occurs.
The Auto-IMT is capable of measuring the thickness of the near and far walls of the carotid artery from three segments of the vessel, and uses the collected images for a diagnosis.
The tool helps to speed up exams and increase diagnostic efficiency, according to Toshiba. For example, the Auto-IMT has helped reduce the time needed to evaluate the artery's wall thickness from 45 minutes to 10 minutes, said David Parlato, director of clinical operations for Midwest Ultrasound, which developed the tool with Toshiba.
The software is now used in Toshiba's Aplio XG, Aplio MX and Xario XG ultrasound systems. And, Midwest Ultrasound will be using the Auto-IMT tool on its 25 Xario XG devices.
“Measuring IMT at a faster pace helps identify high-risk patients before a cardiac episode occurs, which we believe leads to better patient outcomes,” said Tomo Hasegawa, director of Toshiba's ultrasound business unit. “Toshiba is committed to improving patient care and providing ways to streamline processes so patients receive the highest quality care more efficiently.”
Aeolus Pharmaceuticals inks deal worth up to $118 million
Irvine-based Allergan, MAP partner on migraine drug
Amerita acquires San Antonio infusion maker